Avoro Capital Advisors LLC Solid Biosciences Inc. Transaction History

Avoro Capital Advisors LLC

  • $6.86 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$7.33 - $43.15 $2.02 Million - $11.9 Million
-275,000 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$7.19 - $33.17 $1.98 Million - $9.12 Million
275,000 New
275,000 $2.06 Million

Others Institutions Holding SLDB

# of Institutions
2
Shares Held
97
Call Options Held
0
Put Options Held
0
View Full List

About Solid Biosciences Inc.

SLDB Quotes by TradingView
  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $35.2M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email